Geftisafe 250 Mg Red Tablets, Gefitinib | Targeted Therapy, Lung Cancer Medication, Blister Pack
Get Latest Price
In Stock
Product Specifications
| Product Type | Medication Tablets |
| Dominant Color | Red |
| Dosage | 250 mg |
| Active Ingredient | Gefitinib |
| Tablet Count | 10 |
| Form | Tablets |
| Packaging | Blister pack |
| Usage | Treats specific types of lung cancer |
| Manufacturer | Cytocare |
| Features | Cancer treatment, Targeted therapy, Effective dosage, Reliable source |
| Payment Terms | Cash in Advance (CID) |
| Main Export Market(s) | Asia |
| Main Domestic Market | All India |
Product Overview
Key Features
Company Details
Focusing on a customer-centric approach, Cytocare Formulations Pvt. Ltd. has a pan-India presence and caters to a huge consumer base throughout the country. Buy Pharmaceutical Ointments & Creams in bulk from Cytocare Formulations Pvt. Ltd. at Trade India quality-assured products.
Business Type
Manufacturer, Supplier
GST NO
19AADCC6548D1ZN
Related Products
Geftib Tablets 250 Mg - Drug Type: General Medicines
Price: 1390 INR
MOQ - 1 Box/Boxes
Rutika Lifescience Pvt. Ltd
Mumbai, Maharashtra
Geftib Tablets 250 Mg - Ingredients: Natural Yeast
MOQ - 100 Pack/Packs
Speciality Medicine Limited
Mumbai, Maharashtra
Geftib 250mg Tablets - Gefitinib 250mg, White to Off-White Tablets, Oral Anticancer Therapy, Prescription Only
Price: 20.99 INR
MOQ - 10 Box/Boxes
Vikshar Healthcare Private Limited
Mumbai, Maharashtra
GEFTIB 250MG TABLET - Non-Small Cell Lung Cancer Treatment, Abnormal EGFR Gene Targeting, Daily Use for Optimal Efficacy
Price: 3662 INR
MOQ - 5 Bottle/Bottles
Surya Speciality Pharma
Bengaluru, Karnataka
Geftib 250Mg Tablet - Pharmaceutical Grade, Film-Coated | Effective Treatment, Round Tablet, Blister Packaged
K.r. Hospital Care
Ahmedabad, Gujarat
Explore Related Categories
More Products From This Seller
Seller Details
GST - 19AADCC6548D1ZN
Kolkata, West Bengal
Manager
Mr. Sudeep Mitra
Address
70 C, Sadananda Road, Rashbehari, Kolkata, West Bengal, 700026, India
Report incorrect details
